Headline News about Global Blood Therapeutics, Inc. - Common Stock![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]()
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug
May 06, 2021
Via Benzinga
Topics
Earnings
Exposures
Financial
![]() Via Benzinga
Exposures
Product Safety
![]() Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|